http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019078645-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
| filingDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900319202fcff96f6788ef779363eb7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675fb9e76ec65c343eed995090d3363a |
| publicationDate | 2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019078645-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER TREATMENT AND PREPARATION METHOD THEREOF |
| abstract | The present invention relates to a 4-hydroxy-3,5-dialkoxybenzoate alkyl derivative which has the activity of inhibiting the growth of cancer cells and killing cancer cells with the induction of cell death and an anti-cancer composition. comprising. A compound and a composition according to the present invention have the effect of reducing the viability of cancer cells by inducing cell cycle interruption and apoptosis specifically in cancer cells without affecting the viability of normal cells. |
| priorityDate | 2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.